Aimei Health Technology Co., Ltd Ordinary Share (AFJK)
Company Profile
| Quarter (USD) | Sep 24 | Mar 24 | Dec 23 | |
|---|---|---|---|---|
| Revenue | ||||
| Cost of revenue | ||||
| Operating income | ||||
| Operating margin | ||||
| Net income | ||||
| Net profit margin | ||||
| Cash on hand | ||||
| Change in cash | ||||
| Diluted EPS |
| Annual (USD) | Dec 23 | |
|---|---|---|
| Revenue | ||
| Cost of revenue | ||
| Operating income | ||
| Operating margin | ||
| Net income | ||
| Net profit margin | ||
| Cash on hand | ||
| Change in cash | ||
| Diluted EPS |
| 13F holders | Current |
|---|---|
| Total holders | 28 |
| Opened positions | 27 |
| Closed positions | 0 |
| Increased positions | 0 |
| Reduced positions | 0 |
| 13F shares | Current |
|---|---|
| Total value | 57.90 bn |
| Total shares | 10.43 mm |
| Total puts | 0.00 |
| Total calls | 0.00 |
| Total put/call ratio | – |
| Largest owners | Shares | Value |
|---|---|---|
| Cowen And | 1.20 mm | $968.00 mm |
| Karpus Management | 1.10 mm | $11.25 bn |
| Wolverine Asset Management | 900.25 k | $4.76 bn |
| Harraden Circle Investments | 785.00 k | $0.00 |
| Mangrove Partners | 750.00 k | $150.00 mm |
| Vivaldi Asset Management | 680.00 k | $6.98 bn |
| Highbridge Capital Management | 644.66 k | $128.93 mm |
| Shaolin Capital Management | 550.00 k | $3.13 bn |
| Wealthspring Capital | 536.50 k | $5.48 bn |
| Exos Asset Management | 500.00 k | $3.10 bn |
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 Dec 23 | Aimei Investment | Ordinary Shares | Buy | Acquire P | No | No | 10 | 332,000 | 3.32 mm | 1,905,000 |
| 1 Dec 23 | Aimei Investment | Rights Ordinary shares | Buy | Acquire P | No | No | 0 | 332,000 | 0.00 | 332,000 |